Posts tagged with ‘marine bioprospecting’

  • 2012 Symposium on Marine Natural Product Drug Discovery in Aberdeen, Nov 6th

    The 2012 Symposium on Marine Natural Product Drug Discovery will bring together academics and industry representatives from across Europe to discuss groundbreaking research into the development of novel drug candidates from marine natural resources, with particular emphasis on the fields of cancer and on neurodegenerative diseases. The symposium, which is held in the context of the biannual Pharmatlantic consortium meeting, will take […]
    0
  • BIOPROSP ’13 Conference Registration Now Open

    The 6th BIOPROSP Conference A biennial International Conference on Marine Bioprospecting from cold marine environment. To be held in the world’s northernmost University City in February 20th – 22nd in Tromsø, Norway. Conference objective: BIOPROSP_13 will focus on the challenges and possibilities related to industrial applications of marine bioactive compounds Target group: Biotech and pharmaceutical industry, scientists, medicine, cosmetics, public […]
    0
  • Aquapharm announces discovery of novel antibiotic compound

    Scottish biotechnology company Aquapharm Biodiscovery has discovered a novel antibiotic compound with potent activity against a broad spectrum of multi-drug-resistant Gram-positive bacteria. The compound, which demonstrates bactericidal potency against Multi Drug Resistant Staphylococcus Aureus (MDRSA) and Multi Drug Resistant Streptococcus Pneumoniae (MDRSP), Clostridium Difficile and Enteroccocus Faecalis which are common causes of death in patients in hospital care units is the company’s first new […]
    0
  • Norway’s MareLife issues summer newsletter summarizing recent marine biotech-related activities and projects

    Marelife, the independent science-based marine innovation network, has reinforced its staff and put in operation R&D projects initiated by experienced working groups covering key areas in marine innovation. Read their new summer newsletter which sums up the Marelife activities Winter and Spring 2012. More info
    0
  • Mar. Drugs, Volume 10, Issue 6 (June 2012), Pages Pages 1192-1421 Now Available

    MDPI is pleased to announce the availability of the following: Mar. Drugs, Volume 10, Issue 6 (June 2012), Pages Pages 1192-1421 http://www.mdpi.com/1660-3397/10/6/ Table of Contents: Sheila Marie Pimentel-Elardo, Lubomir Grozdanov, Sebastian Proksch and Ute Hentschel Article: Diversity of Nonribosomal Peptide Synthetase Genes in the Microbial Metagenomes of Marine Sponges Mar. Drugs 2012, 10(6), 1192-1202; doi:10.3390/md10061192 http://www.mdpi.com/1660-3397/10/6/1192/ Shwu-Li Wu, Jui-Hsin Su, […]
    0
  • Aquapharm & Medical Research Council evaluate EndoSeaRch- a new approach to digestive health

    Scottish biotechnology firm Aquapharm has joined forces with the Medical Research Council’s Human Nutrition Research unit (MRC HNR) in Cambridge to evaluate the potential of a new approach to digestive health, called EndoSeaRch™. The two parties are seeking to modulate certain bacterial populations of the gastrointestinal tract with orally delivered synthetic minerals in models of Inflammatory Bowel Disease (IBD). These may include […]
    0
  • CSA MarineBiotech Launched

    A sound strategy for marine biotechnology research, technology development and innovation and a concerted coordination of relevant national and regional programmes are urgently needed in Europe. The Coordination and Support Action ‘MarineBiotech’ is a response to this, aiming at an ERA-NET in marine biotechnology that can deliver ‘smart, sustainable and inclusive growth’, a core objective of the Europe 2020 Strategy. Bringing […]
    0
  • ORNL Protein Analysis Investigates Marine Worm Community

    Techniques used by researchers from the Department of Energy’s Oak Ridge National Laboratory to analyze a simple marine worm and its resident bacteria could accelerate efforts to understand more complex microbial communities such as those found in humans. In a paper published in the Proceedings of the National Academy of Sciences, a multi-institutional research team analyzed the proteins found in […]
    0
  • Marine Natural Product Stops Cancer Drug Resistance

    Lamellarins are a class of marine natural products of which some members have shown activity against multidrug resistant cancer lines. These lamellarins act by inhibiting the P-glycoprotein, which enhances transport of anticancer agents out of cancer cells, thus rendering them multidrug resistant. An systematic investigation of structure–activity relationship led by Robert Capon, University of Queensland, Australia, used spectroscopic methods including […]
    0
  • Growing International Interest In Oceanology To Benefit The Global Marine Biotechnology Market, According To New Report By Global Industry Analysts, Inc.

    With growing environmental pollution throwing the spotlight on sustainable industrial development, there exists huge demand for suitable, scalable, economically, socially and environmentally sustainable feedstock options for the manufacturing industry. With sustainable feedstock production and delivery ballooning into a massive industry worldwide, the world’s oceans have emerged into the next frontier for investigative, biological resource development and management R&D projects. For […]
    0